• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[100毫克和50毫克剂量的苯溴马隆对健康受试者的影响]

[Effect of benzbromarone in 100mg and 50mg doses on healthy subjects].

作者信息

Matzkies F, Berg G

出版信息

Fortschr Med. 1977 Jul 21;95(27):1745-7.

PMID:903059
Abstract

After oral application of 100mg of Benzbromarone a significant decrease of the uric acid concentration in the serum up to the 14th day after beginning of the treatment to a mean value of 1,7 mg/100 ml is achieved; while the application of 50 mg of Benzbromarone reduces the uric acid concentration only to a value of 3,4 mg/100 ml. Thereby the differences amounts to about 1,7 mg/100 ml. The urate elimination increases after 100 as well as after 50 mg of Benzbromarone. Only initially an increased uric acid elimination could be observed. In the further course the uric acid elimination remains increased despite reduced serum concentrations.

摘要

口服100毫克苯溴马隆后,在治疗开始至第14天期间,血清尿酸浓度显著降低,平均降至1.7毫克/100毫升;而服用50毫克苯溴马隆仅将尿酸浓度降至3.4毫克/100毫升。因此,差异约为1.7毫克/100毫升。服用100毫克和50毫克苯溴马隆后尿酸排泄均增加。仅在最初可观察到尿酸排泄增加。在后续过程中,尽管血清浓度降低,但尿酸排泄仍保持增加。

相似文献

1
[Effect of benzbromarone in 100mg and 50mg doses on healthy subjects].[100毫克和50毫克剂量的苯溴马隆对健康受试者的影响]
Fortschr Med. 1977 Jul 21;95(27):1745-7.
2
[Treatment of hyperuricemia using daily doses of 50 and 25mg of benzbromarone].[使用每日50毫克和25毫克苯溴马隆治疗高尿酸血症]
Fortschr Med. 1977 Jul 21;95(27):1748-50.
3
[Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
Fortschr Med. 1976 Sep 16;94(26):1427-9.
4
[The effect of benzbromaron in gout patients with limited kidney function].
Fortschr Med. 1979 Nov 22;97(44):2057-61.
5
Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites?苯溴马隆在肝硬化患者中的生物转化及降尿酸作用——苯溴马隆活性代谢产物的证据?
Eur J Med Res. 1995 Oct 16;1(1):16-20.
6
The influence of benzbromarone and its combination with hydrochlorothiazide on renal excretion of uric acid and electrolytes.苯溴马隆及其与氢氯噻嗪联用对尿酸及电解质肾排泄的影响。
Int J Clin Pharmacol Ther Toxicol. 1990 Oct;28(10):443-5.
7
The pharmacology of hypouricemic effect of benzbromarone.苯溴马隆降尿酸作用的药理学
J Rheumatol. 1975 Dec;2(4):437-45.
8
[The effect of benzbromarone on fasting-hyperuricemia as a model (author's transl)].以苯溴马隆对空腹高尿酸血症模型的作用(作者译)
Med Klin. 1978 Jun 9;73(23):861-6.
9
[Uric acid lowering effects of benzbromarone (Harolan) by increasing uric acid excretion].苯溴马隆(立加利仙)通过增加尿酸排泄降低尿酸的作用
Fortschr Med. 1979 May 3;97(17):835-6.
10
[Therapy of hyperuricemia and gout. Effect of a combination therapy of allopurinol with benzbromarone].[高尿酸血症与痛风的治疗。别嘌醇与苯溴马隆联合治疗的效果]
Fortschr Med. 1983 May 26;101(20):953-9.

引用本文的文献

1
Benzbromarone disposition and uricosuric action; evidence for hydroxilation instead of debromination to benzarone.苯溴马隆的处置与促尿酸排泄作用;羟基化而非脱溴生成苯酰马隆的证据。
Klin Wochenschr. 1988 Feb 15;66(4):160-6. doi: 10.1007/BF01727785.
2
Benzbromarone: a review of its pharmacological properties and therapeutic use in gout and hyperuricaemia.苯溴马隆:其药理特性及在痛风和高尿酸血症治疗中的应用综述
Drugs. 1977 Nov;14(5):349-66. doi: 10.2165/00003495-197714050-00002.